Literature DB >> 9708834

Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.

T Sagvolden, J A Sergeant.   

Abstract

This special issue represents an attempt to answer fundamental brain and behaviour issues in attention-deficit hyperactivity disorder (ADHD). The European network on hyperkinetic disorders (Eunethydis) is trying to develop a novel, testable theory of ADHD, giving an account of its causes, its development from brain dysfunctions to behavioural symptoms and co-morbidity and explaining why no current therapy produces long-lasting improvements. The combined insights of the articles presented here suggest that there is no brain damage in ADHD, but hypo-efficient dopamine systems which give rise to neurochemical imbalances. These cause behavioural problems: deficits in sustained attention, overactivity and impulsiveness. Impulsiveness is increasingly being seen as a key characteristic of the disorder. None of these symptoms are necessarily primary, but may be secondary to an underlying deficit in reinforcement processes seen particularly in a greater than normal sensitivity to variations in the timing of stimulus presentation. Other symptoms can also be seen: altered effects of reinforcers, increased behavioural variance and motor co-ordination problems. Medication produces temporary, plastic changes in cellular components like receptors and transduction mechanisms normalising dopamine functions and behaviour. reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708834

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  67 in total

1.  Developmental effects of dietary n-3 fatty acids on activity and response to novelty.

Authors:  Beth Levant; Troy J Zarcone; Stephen C Fowler
Journal:  Physiol Behav       Date:  2010-05-10

Review 2.  From reinforcement learning models to psychiatric and neurological disorders.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Nat Neurosci       Date:  2011-02       Impact factor: 24.884

Review 3.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

4.  Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate.

Authors:  Elizabeth B Liddle; Chris Hollis; Martin J Batty; Madeleine J Groom; John J Totman; Mario Liotti; Gaia Scerif; Peter F Liddle
Journal:  J Child Psychol Psychiatry       Date:  2010-11-12       Impact factor: 8.982

5.  Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains.

Authors:  Pamela B Yang; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2006-10-19       Impact factor: 4.077

Review 6.  The neurobiology and genetics of impulse control disorders: relationships to drug addictions.

Authors:  Judson A Brewer; Marc N Potenza
Journal:  Biochem Pharmacol       Date:  2007-07-03       Impact factor: 5.858

7.  Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex.

Authors:  Lori A Newman; Jenna Darling; Jill McGaughy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-22       Impact factor: 4.530

8.  EUNETHYDIS -- searching for valid aetiological candidates of Attention-Deficit Hyperactivity Disorder or Hyperkinetic Disorder.

Authors:  Joseph Sergeant
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

9.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

Review 10.  Non-stimulant medications in the treatment of ADHD.

Authors:  Tobias Banaschewski; Veit Roessner; Ralf W Dittmann; Paramala Janardhanan Santosh; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.